Effects of dairy consumption on SIRT1 and mitochondrial biogenesis in adipocytes and muscle cells

Nutrition and Metabolism

Volumn 8, Issue , 2011, Pages

  Bruckbauer, Antje ^a   Zemel, Michael B ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Hydroxy Methylbutyrate (HMB); ketoisocaproate (KIC); Adipose tissue; Dairy; Insulin sensitivity; Leucine; Mitochondrial biogenesis; Muscle; SIRT1

Indexed keywords

2 OXOISOCAPROIC ACID; BETA HYDROXY METHYLBUTERIC ACID; CYTOCHROME C OXIDASE; CYTOCHROME OXIDASE C SUBUNIT 7; DRUG METABOLITE; LEUCINE; NUCLEAR RESPIRATORY FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PLACEBO; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SIRTUIN 1; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; BIOGENESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; DAIRY PRODUCT; DIETARY INTAKE; ENZYME ACTIVATION; ENZYME ACTIVITY; EX VIVO STUDY; FEMALE; FOOD INTAKE; GENE EXPRESSION; HUMAN; IN VITRO STUDY; MALE; MITOCHONDRION; MOUSE; MUSCLE CELL; NONHUMAN; OBESITY;

EID: 83655197747     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-8-91     Document Type: Article

References (40)

1. Calorie restriction, SIRT1 and metabolism: understanding longevity. Bordone L, Guarente L, Nat Rev Mol Cell Biol 2005 4 298 305 (Pubitemid 40516896)
2. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Verdin E, Hirschey MD, Finley LW, Haigis MC, Trends Biochem Sci 2010 12 669 75
3. Calorie restriction - the SIR2 connection. Guarente L, Picard F, Cell 2005 120 4 473 82 10.1016/j.cell.2005.01.029 15734680 (Pubitemid 40269762)
4. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. Nemoto S, Fergusson MM, Finkel T, J Biol Chem 2005 280 16 16456 60 10.1074/jbc.M501485200 15716268 (Pubitemid 40616776)
5. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X, Zhai Q, Cell Metab 2007 4 307 19 (Pubitemid 47468091)
6. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Yoshizaki T, Milne JC, Imamura T, Schenk S, Sonoda N, Babendure JL, Lu JC, Smith JJ, Jirousek MR, Olefsky JM, Mol Cell Biol 2009 29 5 1363 74 10.1128/MCB.00705-08 19103747
7. Role of uncoupling protein 2 (UCP2) expression and 1alpha, 25-dihydroxyvitamin D3 in modulating adipocyte apoptosis. Sun X, Zemel MB, FASEB J 2004 18 12 1430 2 15231722 (Pubitemid 39561604)
8. Calcium and dairy modulation of obesity risk. Zemel M, Obes Res 2005 13 1 192 3 10.1038/oby.2005.26 15761181
9. Role of calcium and dairy products in energy partitioning and weight management. Zemel M, Am J Clin Nutr 2004 79 5 907S 12S 15113738
10. Calcitriol and energy metabolism. Zemel MB, Sun X, Nutr Rev 2008 10 Suppl 2 139 46
11. Leucine and calcium regulate fat metabolism and energy partitioning in murine adipocytes and muscle cells. Sun X, Zemel M, Lipids 2007 42 4 297 305 10.1007/s11745-007-3029-5 17406924 (Pubitemid 46668925)
12. Leucine modulation of mitochondrial mass and oxygen consumption in skeletal muscle cells and adipocytes. Sun X, Zemel MB, Nutr Metab (Lond) 2009 6 26 10.1186/1743-7075-6-26
13. 1Alpha,25-dihydroxyvitamin D3 modulation of adipocyte reactive oxygen species production. Sun X, Zemel MB, Obesity (Silver Spring) 2007 15 8 1944 53 10.1038/oby.2007.232 (Pubitemid 47402226)
14. The effects of dairy components on energy partitioning and metabolic risk in mice: a microarray study. Bruckbauer A, Gouffon J, Rekapalli B, Zemel MB, J Nutrigenet Nutrigenomics 2009 2 2 64 77 10.1159/000205936 19690433
15. Dietary Calcium and Dairy Modulation of Oxidative Stress and Mortality in aP2-Agouti and Wild-type Mice. Bruckbauer A, Zemel MB, Nutrients 2009 1 1 50 70 10.3390/nu1010050
16. Effects of dairy compared with soy on oxidative and inflammatory stress in overweight and obese subjects. Zemel MB, Sun X, Sobhani T, Wilson B, Am J Clin Nutr 2010 91 1 16 22 10.3945/ajcn.2009.28468 19889829
17. Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk. Sun X, Zemel MB, J Nutr Biochem 2008 19 6 392 9 10.1016/j.jnutbio.2007.05.013 17869082 (Pubitemid 351685665)
18. Dietary Leucine-An Envrionmental Modifier of Insulin Resistance Acting on Multiple Levels of Metabolism. Macotela Y, Emanuelli B, Bang AM, Espinoza DO, Boucher J, Beebe K, Gall W, Kahn CR, PLoS One 2011 6 6 21187 10.1371/journal.pone.0021187 21731668
19. Sirt1 protects against high-fat diet-induced metabolic damage. Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschop MH, Proc Natl Acad Sci USA 2008 105 28 9793 8 10.1073/pnas.0802917105 18599449 (Pubitemid 352031379)
20. Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammation. Xu F, Gao Z, Zhang J, Rivera CA, Yin J, Weng J, Ye J, Endocrinology 2010 151 6 2504 14 10.1210/en.2009-1013 20339025
21. Role of mitochondrial dysfunction in insulin resistance. Kim JA, Wei Y, Sowers JR, Circ Res 2008 102 4 401 14 10.1161/CIRCRESAHA.107.165472 18309108 (Pubitemid 351651099)
22. Muscular mitochondrial dysfunction and type 2 diabetes mellitus. Schrauwen-Hinderling VB, Roden M, Kooi ME, Hesselink MK, Schrauwen P, Curr Opin Clin Nutr Metab Care 2007 10 6 698 703 10.1097/MCO.0b013e3282f0eca9 18089950 (Pubitemid 350293769)
23. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. Ren J, Pulakat L, Whaley-Connell A, Sowers JR, J Mol Med 2010 88 10 993 1001 10.1007/s00109-010-0663-9 20725711
24. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J, Cell 2006 127 6 1109 22 10.1016/j.cell.2006.11.013 17112576 (Pubitemid 44894520)
25. Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator. Scarpulla RC, Ann N Y Acad Sci 2008 1147 321 34 10.1196/annals.1427.006 19076454
26. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Scarpulla RC, Physiol Rev 2008 88 2 611 38 10.1152/physrev.00025.2007 18391175 (Pubitemid 351520089)
27. Ingestion of whey hydrolysate, casein, or soy protein isolate: effects on mixed muscle protein synthesis at rest and following resistance exercise in young men. Tang JE, Moore DR, Kujbida GW, Tarnopolsky MA, Phillips SM, J Appl Physiol 2009 107 3 987 92 10.1152/japplphysiol.00076.2009 19589961
28. Nutritional role of the leucine metabolite -hydroxy -methylbutyrate (HMB). Nissen SL, Abumrad NN, J Nutr Biochem 1997 8 300 11 10.1016/S0955- 2863(97)00048-X (Pubitemid 27325823)
29. Tissue-specific regulation of 4E-BP1 and S6K1 phosphorylation by alpha-ketoisocaproate. Yoshizawa F, Sekizawa H, Hirayama S, Yamazaki Y, Nagasawa T, Sugahara K, J Nutr Sci Vitaminol (Tokyo) 2004 50 1 56 60 10.3177/jnsv.50.56 (Pubitemid 38405210)
30. Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle? Tischler ME, Desautels M, Goldberg AL, J Biol Chem 1982 257 4 1613 21 6915936 (Pubitemid 12157110)
31. HMB supplementation: clinical and athletic performance-related effects and mechanisms of action. Zanchi NE, Gerlinger-Romero F, Guimaraes-Ferreira L, de Siqueira Filho MA, Felitti V, Lira FS, Seelaender M, Lancha AH Jr, Amino Acids 2011 40 4 1015 25 10.1007/s00726-010-0678-0 20607321
32. Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate. Eley HL, Russell ST, Tisdale MJ, Am J Physiol Endocrinol Metab 2008 295 6 1417 26 10.1152/ajpendo.90567.2008 18840762
33. Beta-Hydroxy-beta-methylbutyrate modifies human peripheral blood mononuclear cell proliferation and cytokine production in vitro. Nunes EA, Lomax AR, Noakes PS, Miles EA, Fernandes LC, Calder PC, Nutrition 2011 27 1 92 9 10.1016/j.nut.2009.12.008 20541366
34. Beta-hydroxy-beta-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modifying nuclear factor-kappaB expression. Nunes EA, Kuczera D, Brito GA, Bonatto SJ, Yamazaki RK, Tanhoffer RA, Mund RC, Kryczyk M, Fernandes LC, Nutr Res 2008 28 7 487 93 10.1016/j.nutres.2008.04.006 19083450 (Pubitemid 351802290)
35. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Lee JH, Song MY, Song EK, Kim EK, Moon WS, Han MK, Park JW, Kwon KB, Park BH, Diabetes 2009 58 2 344 51 19008341
36. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW, EMBO J 2004 23 12 2369 80 10.1038/sj.emboj.7600244 15152190 (Pubitemid 38954844)
37. SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents. Nayagam VM, Wang X, Tan YC, Poulsen A, Goh KC, Ng T, Wang H, Song HY, Ni B, Entzeroth M, Stünkel W, J Biomol Screen 2006 11 8 959 67 10.1177/1087057106294710 17099246 (Pubitemid 44847150)
38. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Yoshizaki T, Schenk S, Imamura T, Babendure JL, Sonoda N, Bae EJ, Oh Dy, Lu M, Milne JC, Westphal C, Bandyopadhyay G, Olefsky JM, Am J Physiol Endocrinol Metab 2010 298 3 419 28 10.1152/ajpendo.00417.2009 19996381
39. AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan. Salminen A, Hyttinen JM, Kaarniranta K, J Mol Med (Berl) 2011 89 7 667 76 10.1007/s00109-011-0748-0
40. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T, Nat Med 2002 8 11 1288 95 10.1038/nm788 12368907 (Pubitemid 35373562)